ESC 365 - undefined undefined undefined

Speaker illustration

undefined undefined undefined

Sessions Presentations

Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt?

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in Special Populations

Session type: Official Joint Session

Hot topics in Asia: cardiac care unit, COVID-19 and acute heart failure

Event: ACVC 2021

Topic: Acute Cardiac Care

Session type: Symposium

Paradigm shifts in HFrEF management: SGLT2-Inhibitors

Event: ESC Asia with APSC & AFC 2020

Topic: Chronic Heart Failure

Session type: Industry Technology and Innovation session

Challenging paradigms and changing the course of chronic kidney disease (CKD) The era of SGLT2i

Event: ESC Asia with APSC & AFC 2020

Topic: Renal Failure and Cardiovascular Disease

Session type: Industry Technology and Innovation session

Closing Session

Event: ESC Asia with APSC & AFC

Topic: Other

Session type: Special Session

APSC Consensus Statements

Event: ESC Asia with APSC & AFC

Topic: Other

Session type: Special Session

Understanding PCSK9 Inhibitors: what, when and why?

Event: ESC Asia with APSC & AFC

Topic: PCSK9-Antagonists

Session type: Satellite Symposium

Controversies in 2019

Event: ESC Asia with APSC & AFC

Topic: Other

Session type: Debate Session

The burden of cardiovascular diseases in 2020: from angina treatment to optimized care of heart failure

Event: ESC Asia with APSC & AFC

Topic: Other

Session type: Satellite Symposium

Personalized tobacco cessation strategies for your patient: patches, drugs or e-cigarettes?

Event: ESC Congress 2019

Topic: Tobacco

Session type: Symposium

ESC 365 is supported by

novartis

Explore sponsored resources